Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AZN | ABBV | NVS | ||
| Company | Astrazeneca Plc ADR | Abbvie Inc | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | ||
| Open | 75.00 | 167.09 | 97.76 | ||
| High | 75.49 | 167.46 | 98.19 | ||
| Low | 74.59 | 157.65 | 97.44 | ||
| Last | 75.17 | 159.62 | 97.44 | ||
| Change | +0.14 | -7.67 | -1.62 | ||
| % Change | +0.19% | -4.58% | -1.64% | ||
| Volume | 6,182,807 | 10,630,765 | 1,467,858 | ||
| 20-Day Average Volume | 6,027,750 | 5,536,428 | 1,900,753 | ||
| Previous Close | 75.03 | 167.29 | 99.06 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 69.16 | 168.36 | 95.29 | ||
| 20-Day Raw Stochastic | 93.21% | 8.12% | 71.19% | ||
| 20-Day Relative Strength | 76.11% | 34.99% | 51.43% | ||
| Weighted Alpha | +9.65 | +5.84 | -4.97 | ||
| Today's Opinion | 88% Buy | 8% Buy | 56% Sell | ||
| Previous Opinion | 88% Buy | 24% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Buy | 96% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.66% since 04/19/24 | -4.08% since 04/19/24 | +3.26% since 04/19/24 | ||
| Low | 69.38 on 04/22/24 | 157.65 on 04/26/24 | 94.72 on 04/22/24 | ||
| High | 75.81 on 04/25/24 | 170.37 on 04/23/24 | 99.50 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +13.33% since 03/26/24 | -10.92% since 03/26/24 | +2.28% since 03/26/24 | ||
| Low | 66.39 on 04/03/24 | 157.65 on 04/26/24 | 92.35 on 04/18/24 | ||
| High | 75.81 on 04/25/24 | 182.30 on 03/28/24 | 99.50 on 04/23/24 | ||
| 3-Month | |||||
| %Chg | +12.03% since 01/26/24 | -2.91% since 01/26/24 | -9.07% since 01/26/24 | ||
| Low | 60.47 on 02/12/24 | 157.65 on 04/26/24 | 92.35 on 04/18/24 | ||
| High | 75.81 on 04/25/24 | 182.89 on 03/12/24 | 107.96 on 01/29/24 | ||
| 6-Month | |||||
| %Chg | +18.55% since 10/26/23 | +9.93% since 10/26/23 | +3.33% since 10/26/23 | ||
| Low | 60.47 on 02/12/24 | 135.85 on 11/09/23 | 92.19 on 10/27/23 | ||
| High | 75.81 on 04/25/24 | 182.89 on 03/12/24 | 108.78 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 232,626,240 | 296,211,520 | 202,478,640 | ||
| Shares Outstanding, K | 3,100,443 | 1,770,647 | 2,044,000 | ||
| Annual Sales | 45,811,000,000 | 54,318,000,000 | 46,660,000,000 | ||
| Annual Net Income | 5,955,000,000 | 4,863,000,000 | 14,850,000,000 | ||
| Last Quarter Sales | 12,024,000,000 | 14,301,000,000 | 7,424,000,000 | ||
| Last Quarter Net Income | 960,000,000 | 822,000,000 | 8,480,000,000 | ||
| 60-Month Beta | 0.50 | 0.58 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.06 on 04/25/24 | 2.79 on 02/02/24 | 1.80 on 04/23/24 | ||
| Latest Earnings Date | 04/25/24 | 04/26/24 | 04/23/24 | ||
| Most Recent Dividend | 0.965 on 02/22/24 | 1.550 on 04/12/24 | 2.431 on 03/07/24 | ||
| Next Ex-Dividends Date | 02/22/24 | 04/12/24 | 03/07/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 19.56 | 15.10 | 14.25 | ||